The United States and United Kingdom have reached an agreement to eliminate import tariffs on pharmaceutical products traded between the two countries. An official announcement is expected at the White House on Monday.
This deal means that pharmaceutical products exported between the US and UK will not face any import taxes, making it easier and potentially cheaper for these goods to move between the two markets.
As part of the agreement, the UK's National Health Service (NHS) will increase the net price it pays for new medicines by 25%.
A tariff is a tax on goods imported from other countries. Removing tariffs can make these goods cheaper for buyers and can encourage more trade.
The agreement includes an increase in the net price the NHS pays for new medicines by 25%. This could lead to higher spending by the NHS on new drugs.
Pharmaceutical companies in both countries may benefit by being able to sell their products in each other's markets without paying import taxes.
Reuters
Skynews
The Guardian
New York Post
WSJ